Skip to main content
. Author manuscript; available in PMC: 2020 Apr 10.
Published in final edited form as: Addict Behav. 2019 Jun 20;100:106027. doi: 10.1016/j.addbeh.2019.06.016

Table 1.

Descriptive characteristics of clients with concurrent alcohol and opioid use.

Overall (n = 1,142) Heroin or Rx Opioid (n = 531) Alcohol + Heroin or Rx Opioid (n = 230) Alcohol, Heroin & Rx Opioid (n = 381) p-value

Male 55.6% 51.7% 60.5% 57.8% 0.05
Mean Age 33.3 33.4 33.7 32.9 0.61
Race 0.08
 White 95.3% 96.4% 93.9% 94.7%
 Black 2.5% 1.7% 4.8% 2.1%
 Other 2.2% 1.9% 1.3% 3.2%
Employed (Yes) 39.5% 41.1% 46.3% 33.3% < 0.00
Reside in County in Appalachia 16.7% 20.1% 12.5% 14.4% 0.02
County Classification 0.32
 Rural 1.5% 1.4% 2.3% 1.1%
 Suburban 1.11% 0.8% 0.5% 2.0%
 Urban 97.4% 97.9% 97.2% 96.9%
Live with Someone AOD Problem (Yes) 39.4% 41.1% 34.6% 39.9% 0.25
Serious Thoughts of Suicide in Lifetime 38.9% 31.4% 40.1% 48.5% < 0.00
Ever Attempted Suicide in Lifetime 19.9% 16.7% 19.7% 24.5% 0.02
Injection Drug Use (Lifetime) 90.8% 91.1% 84.2% 94.2% < 0.00
 Injected drugs in the past month 84.7% 82.5% 84.4% 87.7% 0.13
 Mean age first injected drugs 25.3 26.1b 25.3 24.3b 0.01
Ever Overdosed in Lifetime (Yes) 46.3% 41.3% 43.8% 54.7% < 0.00
 Mean number of times overdosed 2.9 2.7 2.6 3.3 0.04
 Mean age of first overdose 27.3 28.2 27.6 26.3 0.08
Ever Witnessed Overdose in Lifetime (Yes) 73.6% 75.0% 65.5% 76.5% 0.01
 Mean number of times witnessed an overdose 5.0 5.2 4.5 4.5 0.56
Mean number times treated in Emergency Dept. in past 3 months 0.5 0.3b 0.6 0.7b 0.01
Past 3 month drug usea
 Heroin 91.6% 90.6% 80.0% 100.0% < 0.00
 Prescription opioids 61.3% 51.4% 20.0% 100.0% < 0.00
 Cannabis 57.2% 45.5% 59.7% 72.2% < 0.00
 Prescription sedatives 44.4% 31.3% 38.3% 66.7% < 0.00
 Prescription stimulants 18.2% 10.5% 10.6% 66.5% < 0.00
 Cocaine 40.8% 27.7% 36.6% 61.5% < 0.00
 Methamphetamine 13.6% 8.7% 8.0% 24.2% < 0.00
a

Category ‘Other’ is not reported because of few counts.

b

Tukey HSD statistically significant between reference group (no concurrent alcohol & opioid use) versus comparison group.